ArticleCureus2024
Ovarian Stromal Tumor Presenting as Ovarian Torsion: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian sex cord-stromal tumors (SCST) are a rare subset of ovarian neoplasms originating from supportive tissues surrounding oocytes. Despite their rarity, prompt diagnosis and management are crucial due to their potential for diverse clinical presentations and the need to optimize patient outcomes. A 25-year-old female patient was initially diagnosed with pyelonephritis but later discovered to have a large right adnexal mass suspected to be a tubo-ovarian abscess. Further evaluation, including tumor markers and imaging, suggested the possibility of a germ cell tumor or sex-cord stromal tumor, leading to surgical intervention. During surgery, a necrotic tubo-ovarian mass with torsion was found and removed, with subsequent pathology confirming a benign stromal tumor. The patient experienced a smooth recovery postoperatively. The management of ovarian SCST, which is rare and has varied clinical presentations, requires accurate diagnosis and a customized treatment approach. These typically benign tumors can produce steroid hormones, leading to distinct symptoms like virilization or estrogen excess. Diagnostic tools include imaging and tumor markers, while surgical options range from conservative to extensive based on specific tumor and patient characteristics. Post-treatment surveillance involves monitoring symptoms and tumor markers. Advancing the understanding and care of these tumors relies on ongoing research and collaborative, multidisciplinary efforts to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.